Autism-Related Disorders: From ADHD to Genetic Syndromes

Autism spectrum disorder shares biological roots, genetic pathways, and day-to-day symptoms with a surprisingly wide range of other conditions. Some of these, like ADHD and epilepsy, are separate diagnoses that happen to co-occur with autism at high rates. Others, like Fragile X syndrome and Rett syndrome, are single-gene disorders that frequently produce autistic features as part of a broader clinical picture. Still others, including gastrointestinal problems and sleep disturbances, are medical conditions that affect autistic people far more often than the general population. Understanding this network of related conditions matters because it shapes how autism is diagnosed, treated, and researched.

How the Diagnostic Umbrella Changed

Before 2013, what most people now call “autism” was actually split into several separate diagnoses: autistic disorder, Asperger syndrome, childhood disintegrative disorder, and a catch-all category called pervasive developmental disorder-not otherwise specified (PDD-NOS). The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) collapsed all of those into a single diagnosis: autism spectrum disorder (ASD).¹ The new framework also merged what had been two separate symptom domains (social deficits and communication deficits) into one combined domain, alongside a second domain covering restricted and repetitive behaviors.²

That diagnostic reshuffling has practical consequences for anyone trying to understand “autism related disorders.” Conditions that used to be considered distinct subtypes of autism are no longer separate. But conditions that overlap with autism, like ADHD and epilepsy, remain their own diagnoses. The landscape of related disorders now divides roughly into three groups: neurodevelopmental conditions that frequently co-occur, genetic syndromes where autism is a common feature, and medical comorbidities that crop up at elevated rates.

ADHD and Autism

Attention deficit hyperactivity disorder is probably the condition most commonly discussed alongside autism, and for good reason. Symptoms of the two overlap substantially: difficulties with social functioning, trouble with executive skills like planning and organization, and challenges with impulse control show up in both.³ Population-based twin studies have found that the two share genetic heritability, meaning some of the same gene variants raise risk for both conditions.⁴

Until the DSM-5 came along, clinicians were not even allowed to give both diagnoses to the same person. The older manual explicitly said an autism diagnosis precluded an ADHD diagnosis.⁵ That rule created a diagnostic blind spot: children with both sets of symptoms could only receive one label, which often meant one set of difficulties went unaddressed. Since the DSM-5 lifted that restriction, dual diagnosis has become routine, and research into the overlap has expanded.

Despite the shared features, the two conditions remain distinct enough to warrant separate categories. The social difficulties in ADHD tend to stem from impulsiveness and inattention rather than from differences in social understanding itself. A child with ADHD might interrupt a conversation because they cannot wait their turn; a child with autism might struggle to follow the unspoken rules of the conversation in the first place. Research confirms that while overlap is real, qualitative differences in how impairments present themselves separate the two.⁶

Single-Gene Syndromes That Produce Autistic Features

A number of genetic syndromes caused by mutations in a single gene carry autism as a prominent feature. These “monogenic” or “syndromic” forms of autism are especially important to researchers because identifying one gene makes it much easier to study what goes wrong at the cellular level and to develop targeted treatments.⁷

Fragile X Syndrome

Fragile X syndrome is the most common single-gene disorder linked to autism. It results from a mutation in the FMR1 gene on the X chromosome, which is why it tends to be more severe in males (who have only one X). Roughly half of males with Fragile X meet full DSM-5 criteria for autism, and about a fifth of females do.⁸ The degree of autistic features in Fragile X males appears linked to how completely the FMR1 gene is silenced: males whose mutated gene still produces some messenger RNA tend to have higher autism severity scores than those whose gene is fully silenced.⁹ Preclinical studies in Fragile X have identified drug targets aimed at correcting the underlying neural dysfunction, and some have moved into human clinical trials, with the hope that lessons learned could apply to autism more broadly.¹⁰

Rett Syndrome

Rett syndrome is a neurodevelopmental disorder historically classified alongside autism. It is characterized by a period of apparently normal early development followed by regression: children lose purposeful hand use and spoken language, develop repetitive hand movements, and experience gait problems. The majority of Rett syndrome cases are caused by mutations in the MECP2 gene, which regulates transcription across many other genes.¹¹ Because of its distinctive regression pattern and identified genetic cause, Rett is now sometimes classified separately from idiopathic autism, but the overlap in early symptoms means it frequently appears in discussions of autism-related conditions.

Tuberous Sclerosis Complex

Tuberous sclerosis complex (TSC) is caused by mutations in the TSC1 or TSC2 genes, which regulate a cellular growth pathway. Autism co-occurs in an estimated 20 to 60 percent of people with TSC.¹² The connection to the mTOR signaling pathway has been a particularly active area of research because animal models have shown that correcting the underlying molecular defect can improve neurological function even when treatment is started in adulthood, suggesting that some of the brain changes in TSC are reversible rather than purely developmental.¹³

Phelan-McDermid Syndrome

Phelan-McDermid syndrome involves deletions at the tip of chromosome 22, and almost all of these deletions include the SHANK3 gene. SHANK3 encodes a protein that acts as scaffolding in the junctions between neurons, physically connecting receptors at the cell surface to structural proteins inside the cell.¹⁴ Deletions or point mutations in SHANK3 have been directly implicated in autism and intellectual disability, and mouse models with reduced SHANK3 expression show deficits in learning and cognition.¹⁵

Epilepsy

Epilepsy and autism co-occur at rates far above what chance would predict. The connection runs deeper than coincidence: both conditions involve disruptions in the balance between excitatory and inhibitory signaling in neural circuits. Network analyses have found shared genetic modules between the two conditions, with one module centered on ion transport (more epilepsy-focused) and another centered on synaptic signaling (more autism-focused), but both enriched in genes common to both disorders.¹⁶ The single-gene syndromes described above illustrate this overlap vividly: tuberous sclerosis causes both seizures and autistic features through the same molecular pathway, and epilepsy is common in Rett syndrome as well.¹⁷

For families, the clinical implication is that a child diagnosed with autism should be monitored for seizure activity, and vice versa. Some seizure types in young children are subtle and can be mistaken for inattention or behavioral quirks, which makes awareness of the overlap especially important.

The Excitatory-Inhibitory Imbalance Linking Many of These Conditions

A recurring theme across autism-related disorders is disruption in the balance between excitatory and inhibitory signaling in the brain. Glutamate is the main excitatory chemical messenger, and GABA is the main inhibitory one. When the ratio between them shifts, neural circuits become either over-excited or under-dampened, and either direction can produce problems with sensory processing, social cognition, and repetitive behaviors.¹⁸

Animal models reinforce this picture. In mice engineered to carry autism-linked mutations, imbalances between excitation and inhibition are commonly observed, and correcting those imbalances tends to normalize the animals’ autistic-like behaviors.¹⁹ Several of the genes already mentioned, including SHANK3 and the GABA receptor gene GABRB3, directly affect this balance by altering how synapses are built and how signals are transmitted.²⁰ This shared mechanism helps explain why such seemingly different conditions, from Fragile X to epilepsy to idiopathic autism, converge on overlapping symptoms.

Sensory Processing and the Thalamus

Most people with autism report some form of atypical sensory experience: hypersensitivity to sounds or textures, difficulty filtering out background noise, or unusual responses to light and touch. Neuroimaging research points to the thalamus, the brain’s relay station for sensory information, as a key player. In autistic young people, the thalamus shows reduced ability to modulate its connections with the cortex in response to sensory input, which could make it harder to filter and prioritize incoming information.²¹ An increase in connectivity between the thalamus and the amygdala, which flags emotionally important stimuli, may compound the problem by causing the brain to treat irrelevant sensory input as if it demands attention.²²

Studies of high-functioning autistic adults confirm that atypical thalamic connections to the brain’s sensorimotor regions persist into adulthood and are associated with the severity of autism symptoms.²³ The cerebellum, traditionally associated with movement, also appears involved: convergent evidence from imaging, postmortem, and animal studies implicates cerebellar differences in the motor clumsiness, repetitive behaviors, and social difficulties seen in ASD.²⁴

Neuroinflammation

Another thread connecting autism to broader neurological disruption is inflammation in the brain. Microglia, the immune cells of the central nervous system, appear to remain in an activated state in the brains of people with autism. When microglia stay activated for extended periods, they sustain the production of inflammatory molecules that can damage synaptic connections and contribute to neuronal cell death.²⁵ A brain imaging study of young autistic adults found significantly elevated markers of microglial activation across multiple brain regions, including the cerebellum, midbrain, and areas involved in face recognition and social decision-making.²⁶ Whether this inflammation is a cause of symptoms, a consequence of other neural differences, or both remains an open question, but it adds another dimension to the biological picture.

Gut Problems and the Microbiome

Gastrointestinal symptoms, including constipation, diarrhea, and abdominal pain, are extremely common in autistic people. The microbiota-gut-brain axis, the bidirectional communication system between gut bacteria and the brain, has become a major research focus.²⁷ Autistic individuals tend to have different compositions of gut bacteria compared to non-autistic peers, and those microbial differences have been linked to both GI symptoms and behavior.

Microbially targeted therapies, particularly probiotics and fecal microbiota transplantation, have shown early promise for treating GI symptoms in autism, with some evidence of potential benefit for core behavioral symptoms as well. However, the enormous variability within the autism spectrum means that what works for one person may not work for another, and the field is still working out which specific bacterial profiles matter and why.²⁸

Sleep Disturbances and Melatonin

Sleep problems are another condition so common in autism that some researchers view them as a core feature rather than a coincidental comorbidity. Many autistic individuals show reduced melatonin levels, and circadian rhythm disruption is frequently reported.²⁹ The abnormalities go beyond simply making less melatonin: some studies have found that the normal daily rhythm of melatonin production is blunted, with daytime levels staying higher than expected and the difference between day and night levels shrinking.³⁰

Evidence also points to mutations in clock-controlled genes being more common in autism, which suggests the circadian disruption is partly genetic rather than purely behavioral.³¹ Melatonin replacement therapy has produced satisfactory results for sleep disturbances in autism, making it one of the more straightforward interventions available. Beyond sleep, disrupted circadian rhythms during early development may affect synaptic plasticity in ways that increase susceptibility to autism itself.³²

Camouflaging and the Diagnostic Gender Gap

Autism is diagnosed far more often in males than females, but a growing body of research suggests the gap in prevalence may be smaller than it appears. One reason is camouflaging: consciously or unconsciously suppressing autistic traits and mimicking neurotypical social behavior. Autistic females report significantly more camouflaging than autistic males across multiple dimensions, including copying others’ social behavior, masking their own reactions, and compensating for social difficulties with learned scripts.³³

Camouflaging appears to be a significant factor in later diagnosis for individuals without intellectual disability. People diagnosed in adulthood report more camouflaging than those diagnosed in childhood, which suggests that effective masking delays recognition by parents, teachers, and clinicians.³⁴ Systematic reviews have concluded that the discrepancy in prevalence between males and females may be substantially inflated by the fact that females camouflage more effectively.³⁵ This is relevant to the broader theme of autism-related conditions because camouflaging itself carries a mental health cost. Sustained masking is exhausting and is associated with anxiety, depression, and burnout.

Early Detection and Emerging Biomarkers

Behavioral diagnosis of autism typically cannot happen reliably before about 18 months of age, and many children are not diagnosed until years later. Researchers are working on objective biomarkers that could flag risk earlier. Eye-tracking studies have found that an enhanced visual preference for geometric patterns over social images may be an early marker for a subtype of autism associated with more severe symptoms.³⁶

EEG-based approaches are also being explored. Analysis of resting-state brain waves has identified patterns, including reduced long-range connectivity and altered signal complexity, that distinguish autistic individuals from controls. One proof-of-principle study found that a complexity measure computed from resting EEG could serve as a biomarker for ASD risk in infants.³⁷ A systematic review confirmed that EEG-based metrics show promise, with consistently reduced long-range alpha-band connectivity and short-range theta-band connectivity in autistic participants, though more research is needed before any of these measures are ready for clinical use.³⁸

Behavioral Intervention in Early Childhood

The most robust evidence for improving outcomes in young autistic children comes from early intensive behavioral programs. The Early Start Denver Model (ESDM) is one of the best-studied approaches. In a randomized controlled trial of toddlers with autism, those who received ESDM for two years gained an average of about 18 standard-score points in IQ, compared to about 7 points for children receiving community-based interventions. The ESDM group also maintained their rate of growth in adaptive behavior relative to typically developing peers, while the comparison group fell further behind over the same period.³⁹

Importantly, lower-intensity versions of ESDM adapted for inclusive preschool settings have also shown positive results: children improved in active participation, imitation, and language, and the gains generally held at follow-up.⁴⁰ This matters because the full intensive model requires many hours per week of one-on-one therapy, which is not accessible to every family. Evidence that lighter-touch versions can work in real-world preschool environments broadens the reach of the approach.

Aging with Autism

Most autism research focuses on children, which leaves a striking gap in what we know about how autistic people fare across the lifespan. What evidence exists paints a mixed picture. A review of outcomes in autistic older adults found generally poor results across multiple domains: increased medical conditions, low adaptive skills, higher risk of cognitive decline, limited physical activity, elevated rates of mental health conditions, low quality of life, and reduced social participation.⁴¹

That said, one common fear, that autism might accelerate brain aging, does not appear to be supported. A systematic review of cognitive, neural, and physical health findings found that most objective cognitive measures showed comparable age-related patterns in autistic and non-autistic adults. The exception was subjective cognitive complaints, which were consistently higher in autistic participants, meaning autistic adults may feel their thinking is declining even when standardized tests do not confirm it.⁴² Longitudinal work has echoed this: cognitive profiles of younger and older autistic adults did not show age-related changes over time, though mental health difficulties and poor quality of life persisted regardless.⁴³

The real challenge for aging autistic adults appears to be less about cognitive decline and more about the accumulated weight of lifelong mental health difficulties, limited support services designed for adults, and social isolation. Research into interventions and support structures tailored to autistic adults, rather than children, is only now beginning to gain traction.

The Genetic Architecture Underneath

One reason autism connects to so many related conditions is its genetic complexity. While the single-gene syndromes described earlier are individually straightforward, most autism does not trace to one gene. Instead, it involves an additive architecture in which both rare inherited variants and common genetic variation each contribute to risk.⁴⁴ Many of those same gene variants also raise risk for ADHD, epilepsy, intellectual disability, and schizophrenia, which is why autism so often appears alongside other neurodevelopmental and neuropsychiatric conditions rather than in isolation. The overlapping genetic landscape also means that targeted therapies developed for specific syndromes like Fragile X or Rett syndrome could, in principle, benefit people with non-syndromic autism who happen to have disruptions in the same molecular pathways.⁴⁵

1
PubMed Central. Update on diagnostic classification in autism ↩︎
2
PubMed Central. Recent update of autism spectrum disorders ↩︎
3
PubMed Central. The co-occurrence of autism and attention deficit hyperactivity disorder in children – what do we know? ↩︎
4
PubMed. Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations ↩︎
5
PubMed. ADHD and autism: differential diagnosis or overlapping traits? A selective review ↩︎
6
PubMed. Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations ↩︎
7
PubMed Central. Gene Therapies for Monogenic Autism Spectrum Disorders ↩︎
8
PubMed Central. FMR1 and Autism, an Intriguing Connection Revisited ↩︎
9
PubMed Central. Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features ↩︎
10
Frontiers in Cellular Neuroscience. Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes ↩︎
11
PubMed Central. The relationship of Rett syndrome and MECP2 disorders to autism ↩︎
12
PubMed Central. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders ↩︎
13
PubMed Central. Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders ↩︎
14
Molecular Syndromology. The 22q13.3 Deletion Syndrome Phelan-McDermid Syndrome ↩︎
15
PubMed Central. Touchscreen learning deficits and normal social approach behavior in the Shank3B model of Phelan-McDermid Syndrome and autism ↩︎
16
PubMed Central. Multiplex gene and phenotype network to characterize shared genetic pathways of epilepsy and autism ↩︎
17
PubMed Central. Shared Etiology in Autism Spectrum Disorder and Epilepsy with Functional Disability ↩︎
18
PubMed Central. Excitatory/Inhibitory balance in autism spectrum disorders: Integrating genetic, neurotransmitter and computational perspectives ↩︎
19
PubMed. Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders ↩︎
20
PubMed Central. Excitatory/Inhibitory balance in autism spectrum disorders: Integrating genetic, neurotransmitter and computational perspectives ↩︎
21
PubMed Central. Reduced modulation of thalamocortical connectivity during exposure to sensory stimuli in ASD ↩︎
22
PubMed Central. Reduced modulation of thalamocortical connectivity during exposure to sensory stimuli in ASD ↩︎
23
Translational Psychiatry. Thalamocortical connectivity is associated with autism symptoms in high-functioning adults with autism and typically developing adults ↩︎
24
Journal of Psychiatry and Brain Science. Cerebellar Structure and Function in Autism Spectrum Disorder ↩︎
25
PubMed Central. Evidence of microglial activation in autism and its possible role in brain underconnectivity ↩︎
26
JAMA Psychiatry. Microglial Activation in Young Adults With Autism Spectrum Disorder ↩︎
27
PubMed Central. Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation ↩︎
28
PubMed Central. Autism Spectrum Disorder as a Brain-Gut-Microbiome Axis Disorder ↩︎
29
PubMed. Melatonin and Circadian Rhythm in Autism Spectrum Disorders ↩︎
30
PubMed Central. Melatonin and Comorbidities in Children with Autism Spectrum Disorder ↩︎
31
PubMed. Melatonin and Circadian Rhythm in Autism Spectrum Disorders ↩︎
32
PubMed. Autism spectrum disorder (ASD): Disturbance of the melatonin system and its implications ↩︎
33
PubMed. Camouflaging in autism spectrum disorder: Examining the roles of sex, gender identity, and diagnostic timing ↩︎
34
PubMed. Camouflaging in autism spectrum disorder: Examining the roles of sex, gender identity, and diagnostic timing ↩︎
35
PubMed. Social Camouflaging in Females with Autism Spectrum Disorder: A Systematic Review ↩︎
36
PubMed Central. Eye Tracking Reveals Abnormal Visual Preference for Geometric Images as an Early Biomarker of an Autism Spectrum Disorder Subtype Associated With Increased Symptom Severity ↩︎
37
PubMed Central. EEG complexity as a biomarker for autism spectrum disorder risk ↩︎
38
PubMed Central. Systematic Review on EEG Analysis to Diagnose and Treat Autism by Evaluating Functional Connectivity and Spectral Power ↩︎
39
PubMed Central. Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model ↩︎
40
PubMed Central. Effects of a low-intensity Early Start Denver Model-based intervention delivered in an inclusive preschool setting ↩︎
41
PubMed Central. Aging Well and Autism: A Narrative Review and Recommendations for Future Research ↩︎
42
PubMed. Aging in autism: A systematic review of cognitive, neural, and physical health findings ↩︎
43
City, University of London Open Access. Ageing, cognition and quality of life in autism spectrum disorder: cross-sectional and longitudinal studies ↩︎
44
PubMed Central. The contributions of rare inherited and polygenic risk to ASD in multiplex families ↩︎
45
Frontiers in Cellular Neuroscience. Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes ↩︎